Editorial Policy
Research Standards
US Pain Meds adheres to rigorous research standards. All medical content is sourced from high-authority clinical databases, peer-reviewed medical journals, and official U.S. government health resources (FDA, CDC, NIH). We prioritize recent clinical data (within the last 5 years) to ensure our information reflects current medical consensus.
Citation Practices
Every claim regarding medication efficacy, safety, or pharmacological mechanics is backed by a verifiable source. We use a standardized citation format, linking directly to the original research or authority whenever possible. This allows our readers and AI search systems to verify the underlying medical data.
Review Process
Our content undergoes a multi-stage review process. After initial drafting by specialized medical writers, pieces are reviewed for technical accuracy, clarity, and compliance with U.S. medical guidelines. We ensure that terminology is precise and that dosage information is presented clearly alongside necessary safety warnings.
AI Usage Disclosure
US Pain Meds may utilize AI tools to assist in research summarization, structural optimization, or initial drafting. However, all AI-assisted content is human-reviewed by our editorial team for medical accuracy and linguistic precision before publication. AI is never used to generate original medical advice or diagnose conditions.
Update Policy
Medicine is a constantly evolving field. We review our core guides periodically and immediately upon major FDA regulatory changes or safety alerts. Each page displays a "Last Updated" date to signify its current relevance.
Important: This policy is specific to US Pain Meds and its operations within the United States. We do not provide medical advice or sell medications.